PROCEPT BioRobotics Stockholders May Lead Securities Fraud Lawsuit
Rosen Law Firm is urging PROCEPT BioRobotics Corporation stockholders who purchased common stock between February 28, 2024, and February 25, 2026, and incurred losses exceeding $100,000, to consider leading a securities fraud class action.
Press Release
Rosen Law Firm, an international investor rights law firm, is calling on purchasers of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) common stock to potentially lead a securities fraud class action. The lawsuit targets alleged misrepresentations and omissions made during the period from February 28, 2024, to February 25, 2026.
Investors who experienced losses of over $100,000 during this "Class Period" are invited to contact Rosen Law Firm. The firm is seeking lead plaintiffs to guide the litigation. A critical deadline for lead plaintiff filings is approaching in September.
This action highlights potential issues concerning PROCEPT BioRobotics's public disclosures and financial reporting. Investors who wish to serve as lead plaintiff must meet certain legal requirements and are advised to act promptly.
Rosen Law Firm is experienced in prosecuting securities class actions and encourages eligible investors to assess their options. The firm provides consultation to understand the case and the potential role of a lead plaintiff in seeking recovery for affected shareholders.